Lead sponsor
ProMis Neurosciences, Inc
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
1
Ongoing
144
Total enrollment
22
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
1
Trials by status
Active, not recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
PMN310 in Patients With Early Alzheimer's Disease (PRECISE-AD)MCI due to AD / mild AD dementiaPh 1Active, not recruiting144